The serotonin (5-HT) system, one of the most important neurotransmitter systems, has been classified into seven subtypes (5-HT 1-7 ). Among these subfamilies, 5-HT 1A receptors in the central nervous system are strongly implicated in psychiatric disorders such as depression, anxiety and schizophrenia.
1,2 Thus molecular imaging agents for the 5-HT1A have been intensively studied since the past decade. 3, 4 Positron emission tomography (PET) as a non-invasive imaging technique with a high-sensitivity (10 -9 -10 -12 M) and quantitative property, provides the means to visualize receptor densities in living system. 5, 6 PET can play an important role both in assessing the neuropsychiatric disorders and in therapies with already developed pharmaceuticals. 7, 8, 9 It is known that only high affinity agonists bind to receptors while antagonists' binding is relatively insensitive to their affinity. 10, 11 Thereby, a number of antagonist tracers have been developed as PET imaging agents on the basis of the WAY-100635 which is a selective antagonist for 5-HT1A receptors at both somatodendritic and postsynaptic receptor sites. [12] [13] [14] [15] [16] Structural analogues were designed to have stability to metabolism with high affinity, and selectivity for the 5-HT1A. The most important drawback of these compounds is the significant defluorination that causes low-quality images due to contamination of This compound had not only high target-to-non target ratios in receptor rich regions but also little defluorination. 17 However, synthesis of its precursor, trans-N-{2-[4-(2-methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridyl)-N-(4-tosyloxymethylcyclohexane)carboxamide, prior to the fluorination was quite inefficient with the low overall yield for the development of radiopharmaceutical due to the significant breakdown of amide bond, i.e., up to 70% of starting substrate, during the reduction of carbomethoxy group toward WAY-100635 derivative. Thereby, an efficient synthesis of trans-[ 18 F]Mefway precursor is needed which we would like to describe with adaptation of acid chloride-assisted coupling reaction and an improved reduction method.
WAY-100634 (3) was prepared as previously described. 8 Reaction of 2-aminopyridine with chloroacetyl chloride at room temperature provided the 2-(chloroacetyl)amidopyridne (1) (2), which is subsequently reduced to desired product 3, using LiAlH4 in THF at room temperature.
The WAY-100634 was coupled to trans-4-carbomethoxycyclohexanecarbonyl chloride in dichloromethane in the presence of triethylamine at room temperature, yielding trans-N- (4) . In this reaction, we used oxalyl chloride as a coupling agent instead of benzotriazole-1-yloxytris-(dimethylamino)-phosphonium hexafluoro-phosphate (BOP) to enhance reactivity of carboxylic acid. This method improved the reaction yield up to 83% higher than previously reported method using BOP. 17 Specific reduction of carbomethoxy group in 4 was conducted in LiAlH 4 (5) in a 57% yield. This new procedure improves the reaction yield significantly compared to the previous protocol. 17 The treatment of same substrate 5 with LiAlH 4 in THF facilitated significant breakdown of the amide bond to yield compound 3 in more than 60% yield due to the possible presence of adventitious water in THF or unusual reactivity of LiAlH4 in THF solution. 17 For the preparation of the tosylated Mefway precursor 6, the hydroxyl compound 5 was reacted with p-toluenesulfonyl anhydride at room temperature in dichloromethane in the presence of triethylamine to afford the precursor of [ 05 mmol) in dry CH 2 Cl 2 (10 mL), and the mixture was refluxed for 2 h. After removing solvent and unreacted oxalylchloride in vacuo, the product was re-dissolved in dry CH2Cl2. Compound (3) (0.22 g, 1.05 mmol) and TEA (0.16 mL, 1.14 mmol) were added to the previous product at 0 o C. The reaction mixture was stirred at room temperature under an Ar atmosphere for 2 h. After the mixture was washed with 10% aqueous NaHCO3 (100 mL), the organic layer was extracted with CH2Cl2, and dried over anhydrous MgSO4. The residue was purified by flash column chromatography (ethyl acetate, 0.1% v/v TEA) to give product (0.28 g, 83%) as pale yellow oil. 
trans-N-2-{2-[4-(2-Methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridyl)-N-(4-tosyloxymethylcyclohexane)carboxamide (6)
. p-Toluenesulfonyl anhydride (0.018 g, 0.056 mmol) and TEA (0.0072 mL, 0.050 mmol) were added to the solution of compound (5) (0.021 g, 0.046 mmol) in CH2Cl2 (5 mL). The reaction mixture was stirred at room temperature under an Ar atmosphere for 48 h. After the mixture was washed with 10% aqueous NaHCO 3 (100 mL), the organic layer was extracted with CH2Cl2, and dried over anhydrous MgSO4. The residue was purified by gravity column chromatography using neutral silica gel (20:1 CH2Cl2/MeOH) to give product (0.022 g, 75%) as colorless oil. 
